Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

Imbalances in Cardiac Output

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...

Cardiomyopathy IV: Restrictive Cardiomyopathy

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Relative Efficacy of Sacubitril-Valsartan, Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis.

Cardiovascular drugs and therapy·2020

Same author

A new option for monitoring heart failure. First experience in Spain with CardioMEMS.

Medicina clinica·2020

Same author

Trends in Short- and Long-Term ST-Segment-Elevation Myocardial Infarction Prognosis Over 3 Decades: A Mediterranean Population-Based ST-Segment-Elevation Myocardial Infarction Registry.

Journal of the American Heart Association·2020

Same author

Previously Undetected Obstructive Sleep Apnea in Patients With New-Onset Atrial Fibrillation.

The American journal of cardiology·2020

Same author

Short-term changes in left and right systolic function following ferric carboxymaltose: a substudy of the Myocardial-IRON trial.

ESC heart failure·2020

Same author

Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status.

Scientific reports·2020

Search research articles

Related Experiment Video

Updated: Jun 21, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Vascular dysfunction in idiopathic dilated cardiomyopathy.

Santiago Roura¹, Antoni Bayes-Genis

¹ICREC Program, Hospital de la Santa Creu i Sant Pau, Institut Català de Ciències Cardiovasculars (ICCC), Barcelona, Spain.

Nature Reviews. Cardiology

|July 29, 2009

Summary

Idiopathic dilated cardiomyopathy (IDCM) involves heart muscle changes. New research suggests vascular problems, not just heart cell issues, may drive IDCM progression, impacting future therapies.

More Related Videos

Assessing Intracardiac Vortices with High Frame-Rate Echocardiography-Derived Blood Speckle Imaging in Newborns

Assessing Intracardiac Vortices with High Frame-Rate Echocardiography-Derived Blood Speckle Imaging in Newborns

Published on: December 22, 2023

Related Experiment Videos

Last Updated: Jun 21, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Assessing Intracardiac Vortices with High Frame-Rate Echocardiography-Derived Blood Speckle Imaging in Newborns

Assessing Intracardiac Vortices with High Frame-Rate Echocardiography-Derived Blood Speckle Imaging in Newborns

Published on: December 22, 2023

Area of Science:

Cardiology
Vascular Biology
Pathophysiology

Background:

Idiopathic dilated cardiomyopathy (IDCM) is characterized by heart muscle dilation and dysfunction without coronary artery disease.
Traditionally, IDCM focused on cardiomyocyte abnormalities, but cardiac endothelial dysfunction is increasingly linked to disease progression and poor outcomes.
Patients with IDCM exhibit significant vascular derangements, including impaired vasculogenic and angiogenic responses.

Purpose of the Study:

To re-examine the pathophysiology of IDCM.
To investigate the role of vascular derangements as a primary driver of myocyte damage in IDCM.
To highlight the importance of vascular alterations in understanding IDCM progression.

Main Methods:

Review of existing data on IDCM pathophysiology.
Analysis of the association between vascular derangements and cardiomyocyte damage.
Emphasis on the need for relevant animal models.

Main Results:

Cardiac endothelial dysfunction and vascular derangements are significantly associated with IDCM progression and prognosis.
Vascular alterations may precede or contribute significantly to myocyte damage in IDCM.
Current understanding of IDCM pathophysiology needs to incorporate vascular aspects.

Conclusions:

IDCM may be viewed as a downstream consequence of underlying vascular derangements.
Understanding vascular contributions is crucial for developing effective treatments for IDCM.
Development of animal models with marked vascular alterations is essential for future research and therapeutic testing.